surgeons) may wish to use the results to select the type of operation. Even the need to use the results in this way may now come to be obviated by the use of improved surgical techniques suitable for all patients.
Selective surgery for duodenal ulcer was introduced in the 1930s by Somervell and Orr (1936) on the assumption that patients with high acid outputs required a more acid-lowering operation than those with lower acid outputs. In the 1970s surgeons tended to use a vagotomy operation for those in the lower range of secretion, and hypersecretors were treated by partial gastrectomy (in the UK) and vagotomy and antrectomy (in the USA). Data from Copenhagen suggested that recurrent ulceration occurred at an unacceptably high rate after truncal (Kronborg 1974) or selective (Kronborg and Madsen 1976) vagotomy in the third of patients with duodenal ulcer disease with a preoperative peak acid output of >46 mmol/h, and Kronborg considered that those patients' ulcers would not have recurred if their initial operation had been vagotomy and antrectomy. On the other hand in three smaller British series recurrent ulceration was equally common in the lower and upper halves of the range of preoperative maximum acid output (Baron & Spencer 1976) .
There is little evidence to suggest that the recurrence rate in hypersecretors after the new proximal gastric (highly selective) vagotomy is higher than in normosecretors, and this operation seems equally suitable for all patients with duodenal ulcer (Johnston et al. 1975 , Kronborg & Madsen 1975 ).
Thus the main role for gastric secretion tests would seem to be after ulcer operations. After partial gastrectomy tests can help to exclude or support a diagnosis of recurrent ulcer when radiology and endoscopy are unhelpful, and may point to a gastrinoma or the need for further resection or vagotomy. After vagotomy only half the British and only two-thirds of the American surgeons were performing gastric secretion tests in the asymptomatic patient in what should be a routine test of the surgeon's ability to perform an adequate vagotomy (Kay 1967 , Johnston & Goligher 1971 , Baron & Spencer 1976 . There is more general agreement as to the value of measurements of basal, maximal and insulin-stimulated acid output in patients with dyspepsia after vagotomy, in the diagnosis of recurrent ulcer (about 10 %) and to assess residual vagal innervation and decide whether the patient needs repeat vagotomy as well as antrectomy.
Gastric secretion tests need skilled nurses or technicians for their performance, and are unpleasant for the patient. However, their judicious use with careful analysis and interpretation (Baron Are Gastric Secretion Tests Worthwhile?
Clinical biochemistry developed two hundred years ago with the first investigations of human gastric juice (Stevens 1777) . Clinicians are slow to adopt new tests and slow to abandon them when they have later been shown to be unhelpful or superseded by more reliable investigations. Physicians used to measure gastric acid routinely in the diagnosis of pernicious anwemia: now, to assess this condition intrinsic factor secretion and B12 absorption may be measured, doing away with the need to detect achlorhydria to infer non-secretion of intrinsic factor. In the 1970s gastric secretion tests of debatable value were still being performed by gastroenterological physicians and surgeons in the UK (Baron & Alexander Williams 1971) and the USA (Baron, Griffen & Alexander-Williams 1975) . Pentagastrin was marketed in the UK in 1967 and superseded older stimuli of maximum gastric secretion such as histamine and histalog, which were still in use in the USA for a further nine years before pentagastrin became available there.
There seems little place now for routine gastric secretion tests in patients with dyspepsia, even if radiology is negative. Endoscopy is now the investigation of choice and provides direct rather than indirect evidence of any pathological process. Almost every American surgeon and most British surgeons have done gastric secretion tests in patients with gastric ulcer, yet these measurements cannot predict the clinical course or determine the need for surgery. Nor can they establish whether the ulcer is benign, since only one in five gastric carcinomas can be diagnosed from complete anacidity. Gastric ulcers are more appropriately investigated by gastroscopy and biopsy. Most gastroenterologists measured basal and peak acid output routinely in patients with duodenal ulcer, and most used the results in deciding whether the patients should be advised to have an operation. However, prospective series have shown no clear correlation between acid secretion and the need for an operation or the clinical course.
What does seem reasonable is for every patient with duodenal ulcer to have basal and peak acid output measured once the decision to operate has been made on other grounds, if indeed operations are still to be done now that cimetidine is available. Firstly, a high basal acid output (say of > 10 mmol/h) would warrant repeating the test with measurement of fasting serum gastrin, because of the possibility (something like 1 in 1000) of gastrinoma, or the possibility (1 in 100) of G-cell hyperplasia. Secondly, the surgeon (this applied to half the British and almost all the American 1970, 1977) can provide not only advances in clinical science, but also essential answers to specific problems in the medical and surgical management of patients with duodenal ulcer. 
